Inovise Medical
Inovise Receives Breakthrough Device Designation for Novel Non-Invasive System to Remotely Monitor Risk of Decompensation in Heart Failure Patients B2B TECHNOLOGY for Heart Failure TODAY THERE IS AN EMPHASIS TO IMPROVE QUALITY OF LIFE (QOL) AMONG HF PATIENTS WHILE MANAGING SYMPTOMS, DEFINING THE CLINICAL AND ECONOMIC GOALS. 26 M HF patients worldwide 6M in U.S.
Private Company
Funding information not available
About
Inovise Receives Breakthrough Device Designation for Novel Non-Invasive System to Remotely Monitor Risk of Decompensation in Heart Failure Patients B2B TECHNOLOGY for Heart Failure TODAY THERE IS AN EMPHASIS TO IMPROVE QUALITY OF LIFE (QOL) AMONG HF PATIENTS WHILE MANAGING SYMPTOMS, DEFINING THE CLINICAL AND ECONOMIC GOALS. 26 M HF patients worldwide 6M in U.S.